Deals News Hubb
Advertisement Banner
  • Home
  • Business Deals
  • Shopping Deals
  • Contact
No Result
View All Result
  • Home
  • Business Deals
  • Shopping Deals
  • Contact
No Result
View All Result
Gourmet News Hubb
No Result
View All Result
Home Business Deals

U.S. COVID health emergency to stay in place (NYSE:PFE)

admin by admin
November 13, 2022
in Business Deals


JJ Gouin

The U.S. Department of Health and Human Services (HHS) did not notify state officials on Friday that it plans to end the emergency status for COVID-19, signaling that the Biden administration will keep the declaration past January.

The emergency designation, first issued in January 2020 at the start of the pandemic to counter its impact on public health, was renewed every quarter for 90 days.

The HHS pledged to give notice to states 60 days in advance before letting the emergency expire, which would have been Friday if the declaration last renewed in October ended on Jan. 11.

With no such notice on Friday, the public health emergency over COVID-19 may extend until the spring, The Wall Street Journal reported.

The federal designation has allowed millions of Americans to receive free tests, vaccines, and treatments.

The move has also led to a massive expansion of the public health insurance provided via Medicaid and the Children’s Health Insurance Program.

In October, HHS Secretary Xavier Becerra said that how the U.S. faces COVID-19 this fall and winter will help determine whether to renew the emergency declaration.

However, the Biden administration started signaling in August that the emergency status was likely to end in January as plans were underway to transition the government-led procurements of COVID-19 vaccines and therapeutics to the commercial market.

COVID-19 vaccine makers in the U.S.: Pfizer (NYSE:PFE)/ BioNTech (BNTX), Moderna (MRNA), Johnson & Johnson (JNJ), Novavax (NVAX)

Largest U.S. manufacturers of rapid COVID-19 antigen tests: Becton, Dickinson (BDX), Quidel (QDEL), Abbott Laboratories (ABT), Roche (OTCQX:RHHBY)

Developers of COVID-19 treatments: Pfizer (PFE), Merck (MRK), Eli Lilly (LLY)/ AbCellera (ABCL) Gilead (GILD), Eli Lilly (LLY), Vir Biotechnology (VIR)/ GlaxoSmithKline (GSK), Regeneron (REGN)/ Roche (OTCQX:RHHBF)

Largest health insurers: UnitedHealth (UNH), CVS Health Corporation (CVS), Elevance Health (ELV), Cigna (CI), Humana (HUM), Centene (CNC)

Dear Readers: We recognize that politics often intersect with the financial news of the day, so we invite you to click here to join the separate political discussion.



Source link

Previous Post

9 Gifts That Give Back and Make Everyone Feel Warm & Fuzzy

Next Post

Musk fires outsourced Twitter content moderators who track hate

Next Post

Musk fires outsourced Twitter content moderators who track hate

Recommended

Here’s Exactly How Their Policy Works

2 months ago

Elon Musk’s history with ChatGPT maker OpenAI as told by ChatGPT

2 months ago

Elon Musk’s Twitter verification system put ‘rocket boosters’ on climate lies and disinformation

2 weeks ago

10 Big Fashion Trends To Inspire Your Valentine’s Day Outfit

2 weeks ago

Where To Find Magic Mixies On Sale In Time for the Holidays

2 months ago

NextEra Energy plunges as FPL head departs after campaign finance probe (NYSE:NEE)

6 days ago

Deals-(-White-)

© 2022 Deals News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Business Deals
  • Shopping Deals
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Business Deals
  • Shopping Deals
  • Contact

© 2022 Deals News Hubb All rights reserved.